Cargando…

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany

Detalles Bibliográficos
Autores principales: Rossaint, R, Choong, P, Boffard, K, Riou, B, Rizoli, S, Kluger, Y, Christensen, M, Lefering, R, Morris, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092544/
http://dx.doi.org/10.1186/cc4516
_version_ 1782325527260954624
author Rossaint, R
Choong, P
Boffard, K
Riou, B
Rizoli, S
Kluger, Y
Christensen, M
Lefering, R
Morris, S
author_facet Rossaint, R
Choong, P
Boffard, K
Riou, B
Rizoli, S
Kluger, Y
Christensen, M
Lefering, R
Morris, S
author_sort Rossaint, R
collection PubMed
description
format Online
Article
Text
id pubmed-4092544
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40925442014-09-23 Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany Rossaint, R Choong, P Boffard, K Riou, B Rizoli, S Kluger, Y Christensen, M Lefering, R Morris, S Crit Care Poster Presentation BioMed Central 2006 2006-03-21 /pmc/articles/PMC4092544/ http://dx.doi.org/10.1186/cc4516 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Poster Presentation
Rossaint, R
Choong, P
Boffard, K
Riou, B
Rizoli, S
Kluger, Y
Christensen, M
Lefering, R
Morris, S
Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title_full Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title_fullStr Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title_full_unstemmed Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title_short Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
title_sort cost-effectiveness analysis of recombinant activated factor vii as adjunctive therapy for bleeding control in severely injured trauma patients in germany
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4092544/
http://dx.doi.org/10.1186/cc4516
work_keys_str_mv AT rossaintr costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT choongp costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT boffardk costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT rioub costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT rizolis costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT klugery costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT christensenm costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT leferingr costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany
AT morriss costeffectivenessanalysisofrecombinantactivatedfactorviiasadjunctivetherapyforbleedingcontrolinseverelyinjuredtraumapatientsingermany